San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with ...

If you discover a neighbor's dog trespassing in your garden, and you don't want them to, the first recommendation is to ...

Sure, the Cybertruck’s creator, Elon Musk, is a highly polarizing figure. But Christel Virag covered her vehicle in a pinky ...

Hims & Hers rebounded by 11.76 percent on Thursday to close at $46.28 apiece amid reaffirmations to continue offering cheaper ...

Novo Nordisk A/S (NYSE:NVO) is one of the 12 stocks that will make you rich in 10 years. On June 23, the company discontinued ...

The Bartholomew County 4-H Fair opened its Friday schedule with a 4-H Rocket Demonstration north of the Grandstand.

The number of women reporting violent assaults at the hands of former partners has soared 30 per cent in the past five years.

Earlier this week, the pharma giant publicly accused Hims & Hers of “deceptive” marketing that is putting patient safety at risk.

Though much of the dust has settled around Novo Nordisk and Eli Lilly’s crusade against compounded GLP-1s, the recent ...

Labrum is the founder of Meg Matters, a young nonprofit dedicated to suicide prevention and sharing mental health resources ...

Wegovy (semaglutide) will no longer be available through Hims & Hers Health, as Novo Nordisk has ended its short-lived partnership.

Novo Nordisk is expanding access to its drug Wegovy through a new partnership with WeightWatchers, days after cutting ties with telehealth firm Hims & Hers. Starting July 1, WeightWatchers will ...